Literature DB >> 7954742

Platelet superoxide dismutase in migraine and tension-type headache.

T Shimomura1, H Kowa, T Nakano, A Kitano, H Marukawa, K Urakami, K Takahashi.   

Abstract

Superoxide dismutase (SOD) is a radical-scavenging enzyme. We determined Cu, Zn-SOD concentrations and activities in platelets from subjects with migraine and tension-type headaches. Thirty migraine without aura (MWoA) patients, 9 migraine with aura (MWA) patients, and 53 tension-type headache patients were selected for study. Thirty healthy volunteers composed the control group. Concentrations of platelet SOD were determined using enzyme-linked immunosorbent assay techniques. The activity of platelet SOD was determined by measuring reductivity of nitroblue tetrazolium. Low concentrations of platelet SOD were found in patients with MWA and MWoA. Platelet SOD activity decreased in MWA patients but not in patients with MWoA or tension-type headaches. These findings suggest vulnerability to oxidative stress in patients with migraine. It is suggested that low platelet SOD levels may play an important role in the etiology of migraine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954742     DOI: 10.1046/j.1468-2982.1994.014003215.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  15 in total

1.  Is there an association between NC_012920.1: m.8277T> C mitochondrial variation the mt-NC7 locus, and migraine with aura?

Authors:  S Güler; H Gürkan; S Demir
Journal:  Hippokratia       Date:  2020 Apr-Jun       Impact factor: 0.471

2.  Riboflavin and migraine: the bridge over troubled mitochondria.

Authors:  Bruno Colombo; Lorenzo Saraceno; Giancarlo Comi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

3.  Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?

Authors:  Raffaele Palmirotta; Piero Barbanti; Maria Laura De Marchis; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Cristiano Ialongo; Maria Giovanna Valente; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal:  Antioxid Redox Signal       Date:  2014-11-11       Impact factor: 8.401

4.  Paraoxonase 1 (PON1) polymorphisms and risk for migraine.

Authors:  Elena García-Martín; Carmen Martínez; Mercedes Serrador; Hortensia Alonso-Navarro; Francisco Navacerrada; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

Review 5.  Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Authors:  Jonathan M Borkum
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

6.  Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.

Authors:  Ravi Gupta; Rahul Pathak; Manjeet Singh Bhatia; Basu Deb Banerjee
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

7.  Efficacy of combined topiramate/thioctic acid therapy in migraine prophylaxis.

Authors:  Ahmed M Ali; Thanaa G Awad; Nagwa M Al-Adl
Journal:  Saudi Pharm J       Date:  2010-07-30       Impact factor: 4.330

8.  Evaluation of serum uric levels in migraine.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Ali Aygün; Volkan Karabacak; Yavuz Altunkaynak; Dursun Kirbaş
Journal:  Neurol Sci       Date:  2020-07-20       Impact factor: 3.307

9.  A novel oxidative stress marker in migraine patients: dynamic thiol-disulphide homeostasis.

Authors:  Sadiye Gumusyayla; Gonul Vural; Hesna Bektas; Salim Neselioglu; Orhan Deniz; Ozcan Erel
Journal:  Neurol Sci       Date:  2016-05-03       Impact factor: 3.307

Review 10.  Co-occurrence of pain syndromes.

Authors:  Giannapia Affaitati; Raffaele Costantini; Claudio Tana; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Neural Transm (Vienna)       Date:  2019-11-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.